The KIT inhibitor avapritinib (Ayvakit) maintained symptom improvement and reduced mast cell burden in patients with indolent ...
Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...
Obesity is widely known for increasing the risk of diabetes and cardiovascular disease, but its damaging effects on the ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...
The lymphatic system is part of the human immune system. It’s a collection of tissues and vessels that move a fluid called lymph throughout the body. A lymphatic drainage massag ...
CEO Andrew Robbins outlined the company’s transition into a pre-commercial stage at an annual healthcare conference, ...
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication ...